Childhood functional gastrointestinal disorders: Child/adolescent

Childhood functional gastrointestinal disorders: Child/adolescent
复制标题

DOI:
10.1053/j.gastro.2005.08.063
复制
发表时间:
2006-04-01
期刊:
影响因子:
29.4
通讯作者:
Walker, Lynn S.
Walker, Lynn S.
中科院分区:
医学1区
文献类型:
--
作者:
Rasquin, Andree;Di Lorenzo, Carlo;Walker, Lynn S.

文献摘要

被引文献

相似文献

功能性胃肠道疾病的罗马II儿科标准(FGID)是在1999年定义的,作为诊断工具和促进实证研究。在本文件中,罗马第三委员会旨在更新和修订儿科标准。为4-18岁儿童确定罗马III标准的决策过程包括在临床经验和文献审查的基础上达成共识。只要有可能,标准的变化都是基于证据的。否则,在认为必要的时候使用临床经验。几乎没有关于罗马第二标准的出版物可用于指导委员会。涉及的临床实体包括(1)周期性呕吐综合征、沉思和吞气症;(2)与腹痛相关的FGID,包括功能性消化不良、肠易激综合征、腹部偏头痛和功能性腹痛;(3)功能性便秘和非滞留性大便失禁。青少年反思症和功能性便秘是这个年龄段的新定义,以前指定的功能性粪便滞留现在包括在功能性便秘中。从罗马II标准到罗马III标准的其他显著变化包括非周期性疾病的所需症状持续时间从3个月缩短到2个月,以及功能性腹痛标准的修改。罗马III儿童和青少年标准代表了罗马II的演变,应该被证明对处理儿童FGID的临床医生和研究人员都有用。未来更多循证数据的可获得性可能会继续修改FGID的儿科标准。
The Rome II pediatric criteria for functional gastrointestinal disorders (FGIDs) were defined in 1999 to be used as diagnostic tools and to advance empirical research. In this document, the Rome III Committee aimed to update and revise the pediatric criteria. The decision-making process to define Rome III criteria for children aged 4-18 years consisted of arriving at a consensus based on clinical experience and review of the literature. Whenever possible, changes in the criteria were evidence based. Otherwise, clinical experience was used when deemed necessary. Few publications addressing Rome II criteria were available to guide the committee. The clinical entities addressed include (1) cyclic vomiting syndrome, rumination, and aerophagia; 2) abdominal pain-related FGIDs including functional dyspepsia, irritable bowel syndrome, abdominal migraine, and functional abdominal pain; and (3) functional constipation and non-retentive fecal incontinence. Adolescent rumination and functional constipation are newly defined for this age group, and the previously designated functional fecal retention is now included in functional constipation. Other notable changes from Rome II to Rome III criteria include the decrease from 3 to 2 months in required symptom duration for noncyclic disorders and the modification of the criteria for functional abdominal pain. The Rome III child and adolescent criteria represent an evolution from Rome II and should prove useful for both clinicians and researchers dealing with childhood FGIDs. The future availability of additional evidence-based data will likely continue to modify pediatric criteria for FGIDs.